ReviewExperimental hematology & oncology2023

Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies.

Yuqin Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.